In this episode, Lisa speaks with Robert Blum, President and CEO of Cytokinetics about future therapies for HCM and how industry and advocacy can work together to improve the lives of those with HCM. The current status of Cytokinetics clinical trials in HCM is discussed. Q&A included.
Create your
podcast in
minutes
It is Free